2004
Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa
Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH. Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2004, 36: 831-834. PMID: 15213567, PMCID: PMC2745050, DOI: 10.1097/00126334-200407010-00010.Peer-Reviewed Original ResearchConceptsAntiretroviral clinical trialsClinical trialsActive antiretroviral therapyAvailability of HAARTImpact of nonadherenceResource-constrained countriesResource-limited settingsHome-based care servicesAntiretroviral therapyPublic health contextART availabilityDrug costsClinical careTherapy researchConsensus conferenceViral resistanceResearch prioritiesCare servicesGeneric medicationsSuch trialsTherapeutic resourcesTrialsHAARTHIVUrgent research priority
1994
NIH conference. HIV vaccine development: a progress report.
Hoth DF, Bolognesi DP, Corey L, Vermund SH. NIH conference. HIV vaccine development: a progress report. Annals Of Internal Medicine 1994, 121: 603-11. PMID: 8085693, DOI: 10.7326/0003-4819-121-8-199410150-00008.Peer-Reviewed Original ResearchConceptsVaccine candidatesAnimal modelsHuman immunodeficiency virus (HIV) infectionCytotoxic T cell responsesLarge-scale efficacy trialsInnovative vaccine candidatesImmunodeficiency virus infectionT cell responsesCorrelates of immunityEffective preventive vaccineProtective immune responseDiversity of HIVHIV vaccine researchHuman phase IPromising vaccine candidateUseful animal modelPreventive vaccineEfficacy trialsVirus infectionImmune responseVaccine researchSuch trialsPhase ITrialsHIV